Ad is loading...

ANAB AnaptysBio Forecast, Technical & Fundamental Analysis

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Get AI intraday signals

ANAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANAB
(Try 14 days for Free)

View a ticker or compare two or three

Compare

ANAB

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For ANAB
(Try 14 days for Free)

Ad is loading...

A.I. Advisor

published Earnings

ANAB is expected to report earnings to rise 35.96% to -154 cents per share on February 27

Q4'24

Est.

$-1.55

Q3'24

Beat

by $0.56

Q2'24

Missed

by $0.67

Q1'24

Missed

by $0.05

Q4'23

Beat

by $0.04

The last earnings report on November 05 showed earnings per share of -113 cents, beating the estimate of -170 cents. With 145.95K shares outstanding, the current market capitalization sits at 618.01M.

A.I. Advisor

published General Information

General Information

a provider of therapeutic antibodies for inflammation and immuno-oncology

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

10770 Wateridge Circle

Phone

+1 858 362-6295

Employees

117

Web

https://www.anaptysbio.com

Interesting Tickers

MFs / NAME	Price $	Chg $	Chg %
		1 Day
PJGRX	51.83	0.02	+0.04%
PGIM Jennison Growth R
PSTAX	23.23	N/A	N/A
Virtus KAR Capital Growth A
LVFLX	13.87	N/A	N/A
Lord Abbett Focused Large Cap Value R6
NDXKX	39.77	-0.04	-0.10%
Shelton Nasdaq-100 Index K
NWZLX	20.14	-0.03	-0.15%
Nationwide Loomis All Cap Gr A

ANAB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, ANAB has been loosely correlated with CRMD. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if ANAB jumps, then CRMD could also see price increases.

Ticker / NAME	Correlation To ANAB	1D Price Change %
ANAB	100%	+1.70%
CRMD - ANAB	42% Loosely correlated	-2.98%
HRMY - ANAB	42% Loosely correlated	+0.95%
SAGE - ANAB	38% Loosely correlated	N/A
AMRN - ANAB	38% Loosely correlated	+0.75%
PGEN - ANAB	35% Loosely correlated	+5.17%
More